A Safety Trial to Compare Different Analgesics in Combination With Low

Status Completed

Clinical Trial Summary

The purpose of this study is to compare several analgesics given in approved daily doses in combination with a daily cardioprotective dose of aspirin (81 mg), to study their bleeding properties and their effects on the stomach in healthy volunteers.

Clinical Trial Description

The purpose of this randomized, multiple-dose, single-blind, parallel-group study is to examine in healthy volunteers the effects of analgesics given in approved daily doses in addition to daily cardio-protective doses of aspirin (81 mg) on the stomach. All subjects are examined endoscopically before receiving study medication, and at the end of treatment on Day 9. Each subject takes 81 mg of aspirin daily plus one of the following treatments to be taken daily on Days 1 through 8: four doses of acetaminophen 1000 mg, three doses of ibuprofen 400 mg, two doses of naproxen sodium (440 mg in the morning and 220 mg in the evening), four doses of aspirin 650 mg, two doses of celecoxib 200 mg, one dose of rofecoxib 25 mg, or no additional study medication. On Day 9, one dose of aspirin 81 mg and only one dose of the assigned treatment drug are taken prior to having an endoscopy. The primary endpoints of the study are the effects of the analgesics on the inhibition of COX-1 activity by aspirin, and any injury to the stomach mucosa, as determined by direct endoscopic observation. Safety assessments consist of routine monitoring for adverse events, as well as endoscopic examination of gastric mucosa for erosions and ulcerations occurring during the treatment phase. The study hypothesis is that the effects of acetaminophen on the stomach do not differ from the effects of ibuprofen, naproxen, aspirin, celecoxib, or rofecoxib. 81 mg aspirin and 1of 7 treatments for 8 days: acetaminophen 1000mg 4xday, ibuprofen 400mg 3xday, naproxen 440mg morning and 220mg evening, no additional study medication, aspirin 650mg 4xday, celecoxib 200mg 2xday,rofecoxib 25mg 1xday. On Day 9, 1 dose aspirin & 1 dose study drug before endoscopy. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Analgesics

Clinical Trial Details

NCT number	NCT00261586
Study type	Interventional
Source	Johnson & Johnson Consumer and Personal Products Worldwide
Contact
Status	Completed
Phase	Phase 4
Completion date	March 2004

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02987985` - Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy	Phase 3
Recruiting	`NCT05089526` - Opioid-free Anesthesia in Laparoscopic Cholecystectomies	N/A
Terminated	`NCT04489420` - Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM	Phase 1
Completed	`NCT03761433` - Intraoperative Nociception and Postoperative Pain
Recruiting	`NCT04622904` - Lidocaine and Magnesium and Ketamine in Gynecological Surgery	N/A
Recruiting	`NCT05717361` - Opioid Sparing Anesthesia in Cervical Spine Surgery	N/A
Completed	`NCT04818086` - Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use Disorder	Phase 1/Phase 2
Completed	`NCT04254081` - Addition of Buprenorphine to Paracervical Block for Pain Control During Osmotic Dilator Insertion	Phase 4
Recruiting	`NCT03655847` - Acceptable Hemodynamic Changes in Dexmedetomidine for Single Intravenous Bolus Injection	Phase 4
Completed	`NCT02085577` - The Effect of Intraoperative Ketamine on Opioid Consumption and Pain After Spine Surgery in Opioid-dependent Patients	Phase 4
Completed	`NCT01387750` - Mentholated Cream Containing Oxygenated Glycerol Triesters on Acute Pain of the Muscles and Joints	Phase 1/Phase 2
Active, not recruiting	`NCT04365101` - Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19	Phase 1/Phase 2
Active, not recruiting	`NCT04309084` - Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma	Phase 1
Completed	`NCT04369950` - Post-cesarean Analgesia With Epidural Morphine Following Epidural 2-chloroprocaine	Phase 4
Recruiting	`NCT05243940` - Opioid-free Anesthesia in Thyroidectomies	N/A
Recruiting	`NCT04310592` - Natural Killer Cell (CYNK-001) Infusions in Adults With AML	Phase 1
Enrolling by invitation	`NCT06402149` - Comparison of 2 Different Methods in Infraclavicular Block
Completed	`NCT03585088` - The Prediction for Postoperative Pain	N/A
Completed	`NCT02046681` - Monitoring Side Effects Of Pain Medication Prescribing By Emergency Department In Patients Over 65	N/A
Recruiting	`NCT06274814` - U/S Guided Rhomboid Intercostal Block Combined With Sub-Serratus Plane Block vs Type 2 Pectoral Nerve Block	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A Safety Trial to Compare Different Analgesics in Combination With Low Dose Aspirin to Study Their Bleeding Properties and Their Effects on the Stomach

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms